Evidence map›Paper›PMID 37329450›Full record

ArticleDiabetologia2023

Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.

Sandra Hummel, Johanna Carl, Nadine Friedl, Christiane Winkler, Kerstin Kick, Joanna Stock, Franziska Reinmüller, Claudia Ramminger, Jennifer Schmidt, Dominik Lwowsky and 14 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06815081 (A Study to Determine a Capillary Alternative to the Gold Standard Oral Glucose Tolerance Test), which is not on this map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
27.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06815081 recruitingnot on this mapstarted 2024, after this paper: background citation

A Study to Determine a Capillary Alternative to the Gold Standard Oral Glucose Tolerance Test

TypeobservationalSponsorUniversity of OxfordRan2024 to 2027Enrolled135ConditionsType 1 Diabetes (T1D), Type 2 Diabetes
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta-analysis.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Pooled it
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 1 country.

Sandra HummelInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany. sandra.hummel@helmholtz-munich.de.ORCID http://orcid.org/0000-0001-6554-5974
Johanna CarlInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
Nadine FriedlInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
Christiane WinklerInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
Kerstin KickForschergruppe Diabetes at Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany.
Joanna StockInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
Franziska ReinmüllerForschergruppe Diabetes at Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany.
Claudia RammingerInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
Jennifer SchmidtForschergruppe Diabetes e.V. at Helmholtz Zentrum München, Munich, Germany.
Dominik LwowskyNuremberg Hospital South, Nuremberg, Germany.
Sonja BraigPediatric Clinic of the Bayreuth Hospital, Bayreuth, Germany.
Desiree DunstheimerKlinik für Kinder und Jugendliche, Klinikum Augsburg, Augsburg, Germany.
Uwe ErmerSt Elisabeth Klinik, Neuburg an der Donau, Germany.
Eva-Maria GerstlChildren's Hospital Dritter Orden, Passau, Germany.
Leonie WeberHospital Kempten, Kempten, Germany.
Nicole Nellen-HellmuthMVZ Leopoldina, Würzburg, Germany.
Susanne BrämswigRoMed Hospital, Rosenheim, Germany.
Marina SindichakisHospital Traunstein, Traunstein, Germany.
Stefanie TretterHospital Weiden, Weiden, Germany.
Anja LorrmannKJF Klinik Josefinum gGmbH, Augsburg, Germany.
Ezio BonifacioGerman Center for Diabetes Research (DZD), Munich, Germany.ORCID http://orcid.org/0000-0002-8704-4713
Anette-G ZieglerInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.ORCID http://orcid.org/0000-0002-6290-5548
Peter AchenbachInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany. peter.achenbach@helmholtz-munich.de.ORCID http://orcid.org/0000-0001-6720-2684
Fr1da Study Group
Helmholtz Zentrum München · DETUM Klinikum · DEBayreuth Medical Center · DEDeutsches Diabetes-Zentrum e.V. · DEKempten University of Applied Sciences · DEKlinik Donaustauf · DEKlinikum Passau · DEKlinikum Weiden · DELöwenstein Medical (Germany) · DENuremberg Hospital · DERoMed Kliniken · DEUniversity Hospital Augsburg · DE

Funding

Juvenile Diabetes Research Foundation 1-SRA-2014-310-M-RJuvenile Diabetes Research Foundation 3-SRA-2015-72-M-RJuvenile Diabetes Research Foundation 3-SRA-2019-718-Q-R
6 · The paper itself

Abstract

aims/hypothesisWe aimed to determine whether disease severity was reduced at onset of clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type 1 diabetes in a population-based screening programme for islet autoantibodies.

methodsClinical data obtained at diagnosis of stage 3 type 1 diabetes were evaluated in 128 children previously diagnosed with presymptomatic early-stage type 1 diabetes between 2015 and 2022 in the Fr1da study and compared with data from 736 children diagnosed with incident type 1 diabetes between 2009 and 2018 at a similar age in the DiMelli study without prior screening.

resultsAt the diagnosis of stage 3 type 1 diabetes, children with a prior early-stage diagnosis had lower median HbA CONCLUSIONS/

interpretationDiagnosis of presymptomatic type 1 diabetes in children followed by education and monitoring improved clinical presentation at the onset of stage 3 type 1 diabetes.

Indexed as

COVID-19Diabetes Mellitus, Type 1ChildHumansInsulinPandemicsPublic HealthInsulinChildrenEarly-stage diagnosisIslet autoantibodiesScreeningType 1 diabetes

Identifiers

PMID37329450
PMCPMC10390633
OpenAlexW4381053264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.